Cyclic AMP binding proteins in human breast cancer

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Cyclic AMP (cAMP) binding proteins play crucial roles in cellular signaling pathways.
• Aberrant cAMP signaling is implicated in the development and progression of human breast cancer.
• Quantifying cAMP binding proteins in tumor cytosols is essential for understanding their role in breast cancer.

Purpose of the Study:

• To describe and validate a method for measuring cyclic AMP binding proteins in human breast cancer cytosols.
• To assess the levels and variability of these binding proteins in a cohort of breast cancer tumors.

Main Methods:

• Development and application of an assay to quantify cyclic AMP binding proteins in cytosol samples.
• Analysis of binding protein levels (pmol mg-1 cytosol protein) and dissociation constants (M).
• Assessment of assay reproducibility (intra- and inter-assay coefficients of variation) and intra-tumor heterogeneity.

Main Results:

• Cyclic AMP binding proteins were detected in all 100 human breast cancer cytosols analyzed.
• Binding levels varied significantly between individual tumors (0.8–15 pmol mg-1 cytosol protein, mean 5 pmol mg-1).
• Dissociation constants ranged from 0.5–5.2 X 10(-8)M (mean 1.73 X 10(-8)M), with notable intra-tumor variations.

Conclusions:

• The developed assay reliably quantifies cyclic AMP binding proteins in breast cancer cytosols.
• Significant variability in binding protein levels exists both between and within tumors.
• Further research is needed to correlate these variations with tumor characteristics like cellularity and cell type.